- Home
- BATL vs NNVC Comparison
BATL vs NNVC Comparison
Compare BATL & NNVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BATL | NNVC |
|---|---|---|
| Founded | 1987 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.9M | 22.2M |
| IPO Year | 2004 | 2008 |
Fundamental Metrics
Financial Performance| Metric | BATL | NNVC |
|---|---|---|
| Price | $18.76 | $0.95 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 15.6M | 208.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 10.00 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $193,893,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.00 | $0.85 |
| 52 Week High | $29.70 | $2.23 |
Technical Indicators
Market Signals| Indicator | BATL | NNVC |
|---|---|---|
| Relative Strength Index (RSI) | 65.92 | 51.06 |
| Support Level | $1.23 | $0.85 |
| Resistance Level | N/A | $1.07 |
| Average True Range (ATR) | 4.02 | 0.06 |
| MACD | 1.67 | 0.00 |
| Stochastic Oscillator | 59.94 | 68.69 |
Price Performance
Historical ComparisonAbout BATL Battalion Oil Corporation
Battalion Oil Corp is an independent energy company focused on the acquisition, production, exploration, and development of onshore liquids-rich oil and natural gas assets in the U.S. Its properties and drilling activities are currently focused in the Delaware Basin.
About NNVC NanoViricides Inc.
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.